|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.080 USD | +1.89% |
|
-20.00% | -82.35% |
| 06-30 | Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 2000 Dynamic Index | CI |
| 06-29 | Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 3000E Index | CI |
Evolution of the Average Target: Actuate Therapeutics, Inc.
Evolution of the Target Price: Actuate Therapeutics, Inc.
Changes in Analyst Recommendations: Actuate Therapeutics, Inc.
b71373ccf1180f403035ae71b2bc101.vpYgdlO2WYV3SBFN3-Sxy13C_O-GveyTL7Sgv0yAaxs.hvRiF2vlGucoGkEbuK6cmBb2mN7Q7J7hdfmU5hW2Djbs-3IvGvE1yxEffg~dfc6b1caf8a4b65019cd09c139b0b12e
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +841.27% | |||||
| +17.07% | |||||
| +22.32% | |||||
| +31.93% | |||||
| +88.4% | |||||
| +22.04% | |||||
| +25.37% | |||||
| +11.53% | |||||
| -3.74% | |||||
| -7.86% | |||||
| Average | +104.83% | |||||
| Weighted average by Cap. | +24.56% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.060USD
Average target price
9.978USD
Spread / Average Target
+841.27%
High Price Target
14.91USD
Spread / Highest target
+1,306.60%
Low Price Target
5.000USD
Spread / Lowest Target
+371.70%
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| B. Riley |
SellBuy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.060USD
Average target price
9.978USD
Spread / Average Target
+841.27%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACTU Stock
- Consensus Actuate Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
